Iris Acquisition II Corp（IRAB）の株式分析

AI分析 of Iris Acquisition II Corp (IRAB)

中立

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.

バリュエーション指標

Iris Acquisition II Corp（IRAB）の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E

現在のP/E

0.00

予想EV/EBITDA

5年平均 EV/EBITDA

現在のEV/EBITDA

0.00

予想PSR

5年平均 P/S

現在のP/S

0.00

IRAB を保有するクジラ

C

Cable Car Capital LLC

+ を保有IRAB

-4.58%

3か月リターン

A

Aristeia Capital, LLC

+ を保有IRAB

-5.59%

3か月リターン

IRAB のよくある質問 — Alphio AI が回答

Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.